If you are newly diagnosed with cancer and your physician does not participate in clinical trials, keep driving, the CEO of the Sarah Cannon Research Institute (SCRI) told Leadership Health Care on Tuesday, August 2.
Speaking to more than 80 LHC members, Dee Anna Smith shared key information on clinical research and described the innovative advances taking place in Nashville at SCRI.
SCRI is a global strategic research organization focusing on advancing therapies and accelerating drug development. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology, cardiology, gastroenterology and other therapeutic areas through affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites.
Ms. Smith also noted the following facts about cancer diagnosis and treatment:
- Cancer will be diagnosed in 1 in 2 men and 1 in 3 women.
- In the U.S., approximately 1.5 million people were diagnosed in 2010.
- Within five years, cancer will surpass heart disease as the leading cause of death.
- The National Comprehensive Cancer Network believes the best management of any cancer patient is in a clinical trial.
- Once proven safe and effective in a clinical research trial, an intervention or treatment may become the new standard of care
- Only about three percent of patients under treatment are involved in a clinical trial. Increased participation can lead to more effective and targeted therapies and potentially lower costs.
- SCRI works to further the ideal that participation in a clinical trial is the first step in fighting cancer, not the last.
- SCRI is a global strategic research organization focusing on advancing therapies and accelerating drug development. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology, cardiology, gastroenterology and other therapeutic areas through affiliations with a network of more than 700 physicians in the United States and United Kingdom.
- Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites.
View select photos from the LHC Executive Roundtable on Clinical Research below or the full album on Flickr.
